Your Current Position: News and Trends
-
092025-04
-
062020-052020-05-06，The CDE issued a notice to solicit public opinion on the 《Guideline on the Submission of Clinical Trial Data》.
-
302020-042020-04-30，The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)
-
302020-042020-04-30，The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》。
-
302020-04The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》
-
302020-04The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》
-
302020-04TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》
-
292020-04The NMPA issued a notice to solicit public opinion on seven documents , including《Registration Classification and Requirements for Application Materials of Biological Products (Draft for public review)》
-
292020-04The NMPA issued a notice to solicit public opinion on several documents , including《Registration Classification and Requirements for Application Materials of Chemicals (Draft for public review)》
-
292020-04The NMPA issued a notice to solicit public opinion on six documents , including《Special Provisions on Registration Administration of Traditional Chinese Medicine (Draft for public review)》
Beijing Scinovo Laboratories Ltd. Address: 3rd Floor, Building 2, Jinweikai Technology Park, No. 8,Haiying Road, Science City, Fengtai District, Beijing,China |
|
Copyright © Beijing Scinovo Laboratories Ltd. All rights reserved Record number: Beijing ICP No. 17066146